The Nicotine in E-cigarettes Appears to Impair Mucus Clearance


  • newswise-fullscreen The Nicotine in E-cigarettes Appears to Impair Mucus Clearance

    Credit: ATS

    Nicotine in e-cigs and mucus extraction.

Newswise — June 7, 2019─E-cigarette vaping with nicotine appears to hamper mucus clearance from the airways, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.

In “Electronic Cigarette Vapor with Nicotine Causes Airway Mucociliary Dysfunction Preferentially via TRPA1 Receptors,“ a team of researchers from the University of Kansas, University of Miami and Mt. Sinai Medical Center in Miami Beach reports that exposing human airway cells to e-cigarette vapor containing nicotine in culture resulted in a decreased ability to move mucus or phlegm across the surface. This phenomenon is called “mucociliary dysfunction.” The researchers report the same finding in vivo in sheep, whose airways mimic those of humans when exposed to e-cigarette vapor.

“This study grew out of our team’s research on the influence of tobacco smoke on mucus clearance from the airways,” said senior author Matthias Salathe, MD, chair of internal medicine and a professor of pulmonary and critical care medicine at the University of Kansas Medical Center.  “The question was whether vape containing nicotine had negative effects on the ability to clear secretions from the airways similar to tobacco smoke. “

Mucociliary dysfunction is a feature of many lung diseases, including asthma, chronic obstructive pulmonary disease (COPD),  and cystic fibrosis. Specifically, the study found that vaping with nicotine impairs ciliary beat frequency, dehydrates airway fluid and makes mucus more viscous or sticky. These changes make it more difficult for the bronchi, the main passageways to the lung, to defend themselves from infection and injury.

The researchers note that a recent report found that young e-cigarette users who never smoked were at increased risk to develop chronic bronchitis, a condition characterized by chronic production of phlegm that is also seen in tobacco smokers.

Dr. Salathe said the newly published data not only support the earlier clinical report, but help explain it. A single session of vaping can deliver more nicotine to the airways than smoking one cigarette. Moreover, according to Dr. Salathe, absorption into the bloodstream is lower, possibly exposing the airways to high nicotine concentrations for prolonged periods of time.

The study also found that nicotine produced these negative effects by stimulating the ion channel transient receptor potential ankyrin 1 (TRPA1). Blocking TRPA1 reduced the effects of nicotine on clearance in both the human cells in culture and in the sheep.

“Vaping with nicotine is not harmless as commonly assumed by those who start vaping, At the very least, it increases the risk of chronic bronchitis.” Dr. Salathe said. “Our study, along with others, might even question e-cigarettes as a harm reduction approach for current smokers with respect to chronic bronchitis/COPD.”

Contact for Media

Matthias Salathe, MD

msalathe@kumc.edu

Share via Twitter

“The #nicotine in #e-cigarettes appears to impair #mucus clearance in the #airways. This mucociliary dysfunction is a feature of #asthma, #COPD, #cystic fibrosis and other #lung diseases and challenges the perception that #vaping is safer than smoking.  @atscommunity @ATSBlueEditor @KUnews”

About the American Journal of Respiratory and Critical Care Medicine

The AJRCCM is a peer-reviewed journal published by the American Thoracic Society. The Journal takes pride in publishing the most innovative science and the highest quality reviews, practice guidelines and statements in pulmonary, critical care and sleep medicine. With an impact factor of 15.239, it is one of the highest ranked journals in pulmonology. Editor: Jadwiga Wedzicha, MD, professor of respiratory medicine at the National Heart and Lung Institute (Royal Brompton Campus), Imperial College London, UK.

About the American Thoracic Society

Founded in 1905, the American Thoracic Society is the world's leading medical association dedicated to advancing pulmonary, critical care and sleep medicine. The Society’s more than 16,000 members prevent and fight respiratory disease around the globe through research, education, patient care and advocacy. The ATS publishes three journals, the American Journal of Respiratory and Critical Care Medicine, the American Journal of Respiratory Cell and Molecular Biology and the Annals of the American Thoracic Society.

The ATS will hold its 2020 International Conference, May 15-20, in Philadelphia, Pennsylvania, where world-renowned experts will share the latest scientific research and clinical advances in pulmonary, critical care and sleep medicine.

  • share-facebook-The Nicotine in E-cigarettes Appears to Impair Mucus Clearance
  • share-twitter-The Nicotine in E-cigarettes Appears to Impair Mucus Clearance

Comment/Share

Chat now!